Brief Report: Immune Factors in Autism: A Critical Review

Journal of Autism and Developmental Disorders

Volumn 32, Issue 4, 2002, Pages 337-345

  Krause, Ilan ^a,b   He, Xiao Song ^c   Gershwin, M Eric ^c   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autistic disorder; Autoantibodies; Autoimmunity; Immune dysregulation; Intravenous immunoglobulins; NK cells; T cells; Vaccination

Indexed keywords

IMMUNOGLOBULIN; AUTOANTIBODY; HLA DR ANTIGEN;

AUTISM; AUTOIMMUNITY; CHILD DEVELOPMENT; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INFECTION RISK; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; REVIEW; VACCINATION; AUTOIMMUNE DISEASE; IMMUNOLOGY; NATURAL KILLER CELL; T LYMPHOCYTE;

AUTISTIC DISORDER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; KILLER CELLS, NATURAL; T-LYMPHOCYTES;

EID: 0036677088     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016391121003     Document Type: Review

References (82)

1. Abedi-Valugerdi, M., Hu, H., & Moller, G. (1997). Mercury-induced renal immune complex deposits in young (NZB × NZW)F1 mice: Characterization of antibodies/autoantibodies. Clinical and Experimental Immunology, 110, 86-91.
2. Afzal, M. A., Minor, P. D., Ghosh, S., & Jin, L. (2001). Measles virus persistence in specimens of inflammatory bowel disease and autism cases. Digestive Diseases Science, 46, 658-660.
3. Akashi, K., Nagasawa, K., Mayumi, T., Yokota, E., Oochi, N., & Kusaba, T. (1990). Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins. Journal of Rheumatology 17, 375-379.
4. Ando, T., & Dunn, A. J. (1999). Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice. Neuroimmunomodulation, 6, 319-329.
5. Arsura, E. L., Bick, A., Brunner, N. G., & Grob, D. (1988). Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. American Journal of Medicine and Science, 295, 438-443.
6. Bagenstose, L. M., Salgame, P., & Monestier, M. (1999). Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. Environmental Health Perspective, 107 Suppl 5, 807-810.
7. Bagentose, L. M., Salgame, P., & Monestier, M. (1999). Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunology Research, 20, 67-78.
8. Berkman, S. A., Lee, M. L., & Gale, R. P. (1988). Clinical uses of intravenous immunoglobulins. Seminars in Hematology, 25, 140-158.
9. Binstock, T. (2001). Intra-monocyte pathogens delineate autism subgroups. Medical Hypotheses, 56, 523-531.
10. Bronstein, J. M., DeSalles, A., & DeLong, M. R. (1999). Stereotactic pallidotomy in the treatment of Parkinson disease: An expert opinion. Archives of Neurology, 56, 1064-1069.
11. Carper, R. A., & Courchesne, E. (2000). Inverse correlation between frontal lobe and cerebellum sizes in children with autism. Brain, 123, 836-844.
12. Chadwick, N., Bruce, I. J., Schepelmann, S., Pounder, R. E., & Wakefield, A. J. (1998). Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. Journal of Medical Virology, 55, 305-311.
13. Cohen, A. D., & Shoenfeld, Y. (1996). Vaccine-induced autoimmunity. Journal Autoimmunology, 9, 699-703.
14. Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., & Peeden, J. N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology, 14, 388-394.
15. Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics, 134, 607-613.
16. Cook, E. H., Jr., Perry, B. D., Dawson, G., Wainwright, M. S., & Leventhal, B. L. (1993). Receptor inhibition by immunoglobulins: Specific inhibition by autistic children, their relatives, and control subjects. Journal of Autism and Developmental Disorders, 23, 67-78.
17. Deb, S., & Thompson, B. (1998). Neuroimaging in autism. British Journal of Psychiatry, 173, 299-302.
18. DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cunningham-Rundles, C., & Hollander, E. (1999). Brief report: A pilot open clinical trial of intravenous immunoglobulin in childhood autism. Journal of Autism and Developmental Disorders, 29, 157-160.
19. Dunn, A. J., Wang, J., & Ando, T. (1999). Effects of cytokines on cerebral neurotransmission: Comparison with the effects of stress. Advances in Experimental Medicine and Biology, 461, 117-127.
20. Field, E. J., Caspary, E. A., & Carnegie, P. R. (1971). Lymphocyte sensitization to basic protein of brain in malignant neoplasia: Experiments with serotonin and related compounds. Nature, 233, 284-286.
21. Goto, M., Tanimoto, K., Chihara, T., & Horiuchi, Y. (1981). Natural cell-mediated cytotoxicity in Sjogren's syndrome and rheumatoid arthritis. Arthritis and Rheumatology, 24, 1377-1382.
22. Goto, M., Tanimoto, K., & Horiuchi, Y. (1980). Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody. Arthritis and Rheumatology, 23, 1274-1281.
23. Gross, K., Combe, C., Kruger, K., & Schattenkirchner, M. (1995). Arthritis after hepatitis B vaccination. Report of three cases. Scandinavian Journal of Rheumatology, 24, 50-52.
24. Gupta, S., Aggarwal, S., & Heads, C. (1996). Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics. Journal of Autism and Developmental Disorders, 26, 439-452.
25. Gupta, S., Aggarwal, S., Rashanravan, B., & Lee, T. (1998). Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. Journal of Neuroimmunology, 85, 106-109.
26. Haraoui, B., Strand, V., & Keystone, E. (2000). Biologic agents in the treatment of rheumatoid arthritis. Current Pharmacology and Biotechnology, 1, 217-233.
27. Hardan, A. Y., Minshew, N. J., Mallikarjuhn, M., & Keshavan, M. S. (2001). Brain volume in autism. Journal of Child Neurology, 16, 421-424.
28. Hemmerich, P., Neu, E., Macht, M., Peter, H. H., Krawinkel, U., & von Mikecz, A. (1998). Correlation between chlamydial infection and autoimmune response: Molecular mimicry between RNA polymerase major sigma subunit from Chlamydia trachomatis and human L7. European Journal of Immunology, 28, 3857-3866.
29. Horwitz, D. A., Gray, J. D., Ohtsuka, K., Hirokawa, M., & Takahashi, T. (1997). The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity. Immunology Today, 18, 538-542.
30. Hu, H., Abedi-Valugerdi, M., & Moller, G. (1997). Pretreatment of lymphocytes with mercury in vitro induces a response in T cells from genetically determined low-responders and a shift of the interleukin profile. Immunology, 90, 198-204.
31. Hultman, P., Lindh, U., & Horsted-Bindslev, P. (1998). Activation of the immune system and systemic immune-complex deposits in Brown Norway rats with dental amalgam restorations. Journal of Dental Research, 77, 1415-1425.
32. Ilback, N. G. (1991). Effects of methyl mercury exposure on spleen and blood natural killer (NK) cell activity in the mouse. Toxicology, 67, 117-124.
33. Jayne, D. R., Davies, M. J., Fox, C. J., Black, C. M., & Lockwood, C. M. (1991). Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet, 337, 1137-1139.
34. Johansson, U., Hansson-Georgiadis, H., & Hultman, P. (1998). The genotype determines the B cell response in mercury-treated mice. International Archives of Allergy and Immunology, 116, 295-305.
35. Kawashima, H., Mori, T., Kashiwagi, Y., Takekuma, K., Hoshika, A., & Wakefield, A. (2000). Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Digestive Diseases Science, 45, 723-729.
36. Kaye, J. A., del Mar Melero-Montes, M., & Jick, H. (2001). Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. British Medical Journal, 322, 460-463.
37. Kowal, C., Weinstein, A., & Diamond, B. (1999). Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus. European Journal of Immunology, 29, 1901-1911.
38. Krause, I., Hacham, S., Gilburd, B., Damianovitch, M., Blank, M., & Shoenfeld, Y. (1995). Absence of anti-idiotypic antibodies in IVIG preparations to autoantibodies of rare autoimmune diseases. Clinical Immunology Immunopathology, 77, 229-235.
39. Levy, Y., Sherer, Y., Ahmed, A., Langevitz, P., George, J., Fabbrizzi, F., Terryberry, J., Meissner, M., Lorber, M., Peter, J. B., & Shoenfeld, Y. (1999). A study of 20 SLE patients with intravenous immunoglobulin - clinical and serologic response. Lupus, 8, 705-712.
40. Lilic, D., & Ghosh, S. K. (1994). Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet, 344, 1292-1293.
41. Mackay, I. R., Van de Water, J., & Gershwin, M. E. (2000). Autoimmunity. Thoughts for the millennium. Clinical Reviews of Allergy and Immunology, 18, 87-117.
42. Matthys, P., Vermeire, K., & Billiau, A. (2001). Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-gamma in autoimmune disease models. Trends in Immunology, 22, 367-371.
43. Nicoll, A., Elliman, D., & Ross, E. (1998). MMR vaccination and autism 1998. British Medical Journal, 316, 715-716.
44. Nieminen, U., Peltola, H., Syrjala, M. T., Makipernaa, A., & Kekomaki, R. (1993). Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatrics, 82, 267-270.
45. Parke, A. (1992). The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses. Clinical Review of Allergy, 10, 105-118.
46. Peltola, H., Patja, A., Leinikki, P., Valle, M., Davidkin, I., & Paunio, M. (1998). No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet, 351, 1327-1328.
47. Plioplys, A. V. (1998). Intravenous immunoglobulin treatment of children with autism. Journal of Children Neurology, 13, 79-82.
48. Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E. (1994). Lymphocyte function in autism and Rett syndrome. Neuropsychobiology, 29, 12-16.
49. Plioplys, A. V., Greaves, A., & Yoshida, W. (1989). Anti-CNS antibodies in childhood neurologic diseases. Neuropediatrics, 20, 93-102.
50. Rapin, I. (1997). Autism. New England Journal of Medicine, 337, 97-104.
51. Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, J., Kalaydjieva, L., McCague, P., Dimiceli, S., Pitts, T., Nguyen, L., Yang, J., Harper, C., Thorpe, D., Vermeer, S., Young, H., Hebert, J., Lin, A., Ferguson, J., Chiotti, C., Wiese-Slater, S., Rogers, T., Salmon, B., Nicholas, P., Petersen, P. B., Pingree, C., McMahon, W., Wong, D. L., Cavalli-Sforza, L. L., Kraemer, H. C., & Myers, R. M. (1999). A genomic screen of autism: Evidence for a multilocus etiology. American Journal of Human Genetics, 65, 493-507.
52. Romagnani, S. (1995). Biology of human TH1 and TH2 cells. Journal of Clinical Immunology, 15, 121-129.
53. Rose, N. R., & Bona, C. (1993). Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunology Today, 14, 426-430.
54. Rossi, F., & Legras, J. F. (2000). [Viral safety: European and French directives]. Annales Medecine Interne (Paris), 151 Suppl 1, S55-S61.
55. Rumsey, J. M., & Ernst, M. (2000). Functional neuroimaging of autistic disorders. Mentally Retarded Developmental Disabilities Research and Review, 6, 171-179.
56. Shoenfeld, Y. (1994). Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB Journal, 8, 1296-1301.
57. Shoenfeld, Y., & Aron-Maor, A. (2000). Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? Journal of Autoimmunity, 14, 1-10.
58. Singh, V. K., Fudenberg, H. H., Emerson, D., & Coleman, M. (1988). Immunodiagnosis and immunotherapy in autistic children. Annals of New York Academy of Science, 540, 602-604.
59. Singh, V. K., Lin, S. X., & Yang, V. C. (1998). Serological association of measles virus and human herpesvirus-6 with brain auto-antibodies in autism. Clinical Immunology Immunopathology, 89, 105-108.
60. Singh, V. K., Singh, E. A., & Warren, R. P. (1997). Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biological Psychiatry, 41, 753-755.
61. Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain Behavioral Immunology, 7, 97-103.
62. Smeeth, L., Hall, A. J., Fombonne, E., Rodrigues, L. C., Huang, X., & Smith, P. G. (2001). A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. BMC Public Health, 1, 2.
63. Strauss, B., & Bigham, M. (2001). Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism? Can Commun Dis Rep, 27, 65-72.
64. Stubbs, E. G. (1976). Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. Journal of Autism and Childhood Schizophrenia, 6, 269-274.
65. Stubbs, E. G., & Crawford, M. L. (1977). Depressed lymphocyte responsiveness in autistic children. Journal of Autism and Childhood Schizophrenia, 7, 49-55.
66. Taylor, B., Miller, E., Farrington, C. P., Petropoulos, M. C., Favot-Mayaud, I., Li, J., & Waight, P. A. (1999). Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet, 353, 2026-2029.
67. Todd, R. D., & Ciaranello, R. D. (1985). Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proceedings of National Academy of Science of the United States of America, 82, 612-616.
68. Tomer, Y., & Shoenfeld, Y. (1992). Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clinical Experimental Rheumatology, 10, 391-393.
69. Trottier, G., Srivastava, L., & Walker, C. D. (1999). Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. Journal of Psychiatry and Neuroscience, 24, 103-115.
70. Tudela, P., Marti, S., & Bonal, J. (1992). Systemic lupus erythematosus and vaccination against hepatitis B. Nephron, 62, 236.
71. Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., Montgomery, S. M., Davies, S., O'Leary, J. J., Berelowitz, M., & Walker-Smith, J. A. (2000). Enterocolitis in children with developmental disorders. American Journal of Gastroenterology, 95, 2285-2295.
72. Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., Casson, D. M., Malik, M., Berelowitz, M., Dhillon, A. P., Thomson, M. A., Harvey, P., Valentine, A., Davies, S. E., & Walker-Smith, J. A. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351, 637-641.
73. Wakefield, A. J., Pittilo, R. M., Sim, R., Cosby, S. L., Stephenson, J. R., Dhillon, A. P., & Pounder, R. E. (1993). Evidence of persistent measles virus infection in Crohn's disease. Journal of Medical Virology, 39, 345-353.
74. Warren, R. P., Foster, A., & Margaretten, N. C. (1987). Reduced natural killer cell activity in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333-335.
75. Warren, R. P., Margaretten, N. C., Pace, N. C., & Foster, A. (1986). Immune abnormalities in patients with autism. Journal of Autism and Developmental Disorders, 16, 189-197.
76. Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., & Torres, A. R. (1996). Strong association of the third hypervariable region of HLA-DR beta 1 with autism. Journal of Neuroimmunology, 67, 97-102.
77. Warren, R. P., & Singh, V. K. (1996). Elevated serotonin levels in autism: association with the major histocompatibility complex. Neuropsychobiology, 34, 72-75.
78. Warren, R. P., Singh, V. K., Averett, R. E., Odell, J. D., Maciulis, A., Burger, R. A., Daniels, W. W., & Warren, W. L. (1996). Immunogenetic studies in autism and related disorders. Molecular and Chemical Neuropathology, 28, 77-81.
79. Warren, R. P., Yonk, J., Burger, R. W., Odell, D., & Warren, W. L. (1995). DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology, 31, 53-57.
80. Warren, R. P., Yonk, L. J., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990). Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunological Investigations, 19, 245-251.
81. Westall, F. C., & Root-Bernstein, R. S. (1983). Suggested connection between autism, serotonin, and myelin basic protein. American Journal of Psychiatry, 140, 1260-1261.
82. Yuwiler, A., Shih, J. C., Chen, C. H., Ritvo, E. R., Hanna, G., Ellison, G. W., & King, B. H. (1992). Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. Journal of Autism and Developmental Disorders, 22, 33-45.